What We Do

What We Do

Everyone involved with OneMore shares our passion to bring new advances to pancreatic cancer patients as rapidly as possible; providing the only coordinated effort in the world dedicated to rapidly translating research discoveries into new treatments and supportive care for patients with pancreatic cancer.

The OneMore alliance is focused on an all out effort to identify the genes that may reveal one's predisposition to getting the disease and understanding the genetic changes contributing to its development and resistance to therapy. Experiments that were impossible and impractical only a few years ago are now conducted every day, leading us to earlier diagnoses and smarter treatments. 

In addition, we continue to develop novel therapies for the cure of pancreatic cancer, design relevant clinical trials and help launch fundraising programs to support these activities.

 Through our international partnerships with academic, clinical, and corporate entities, it is our mission to deliver all relevant discoveries to the patient bedside in the form of improved healthcare interventions more rapidly than ever.


OneMore focuses on preventing and curing pancreatic cancer by aggressively pursuing the genetic causes of the disease and the rapid translation of new information into more effective treatments.


While OneMore's efforts to cure pancreatic cancer are advancing at an unprecedented rate, funding is needed to continue our unique international effort.

Lee Hanley Hotline

Named after Lee Hanley, the Hotline provides information on all things pancreatic cancer, including research, trials and avenues of support for patients and their families.